This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Atea Pharmaceuticals’s 8K filing here.
Atea Pharmaceuticals Company Profile
Atea Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics for patients with viral infections. Its lead product candidate is AT-527, an oral antiviral candidate that is in Phase 3 SUNRISE-3 clinical trial for the treatment of patients with COVID-19.
Further Reading
- Five stocks we like better than Atea Pharmaceuticals
- Financial Services Stocks Investing
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- How to invest in marijuana stocks in 7 steps
- Breakout Alert: Qualcomm Just Hit The Rally Button
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
